Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1346500 | 0.94 | PTGS2 (0.53) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL11524757 | 0.92 | PTGS2 (0.54) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL9176625 | 0.92 | PTGS2 (0.54) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL9171692 | 0.92 | PTGS2 (0.54) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL9177320 | 0.92 | PTGS2 (0.54) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL3628525 | 0.87 | MEN1 (0.54) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL8672850 | 0.87 | PTGS2 (0.59) | TLR8PTGS2MAPTNPSR1ALDH1A1 | |
| SCHEMBL28126730 | 0.85 | MEN1 (0.52) | TLR8PTGS2MEN1KMT2APOLB | |
| Hydrochloric Acid SCHEMBL16445779 | 0.85 | MEN1 (0.52) | TLR8PTGS2MEN1KMT2APOLB | |
| SCHEMBL9696731 | 0.84 | POLB (0.65) | TLR8PTGS2MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11804314-B2 | Processes for making electrical cables | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2023-10-31 | — | — | US | disclosed |
| CN-111328423-B | Electrical conductors and methods of making and using same | 斯伦贝谢技术有限公司 | 2022-05-03 | — | — | CN | disclosed |
| US-20210158991-A1 | ELECTRICAL CABLES AND PROCESSES FOR MAKING AND USING SAME | SCHLUMBERGER TECHNOLOGY CORP (US) | 2021-05-27 | — | — | US | disclosed |
| CN-111328423-A | Electrical conductors and methods of making and using same | 斯伦贝谢技术有限公司 | 2020-06-23 | — | — | CN | disclosed |
| US-10354777-B2 | Electrical conductors and processes for making and using same | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2019-07-16 | — | — | US | disclosed |
| US-20190088386-A1 | ELECTRICAL CONDUCTORS AND PROCESSES FOR MAKING AND USING SAME | SCHLUMBERGER TECHNOLOGY CORPORATION | 2019-03-21 | — | — | US | disclosed |
| US-20190003278-A1 | PACKOFF SEALS AND PROCESSES FOR USING SAME | SCHLUMBERGER TECHNOLOGY CORPORATION | 2019-01-03 | — | — | US | disclosed |
| US-20180350488-A1 | ELECTRICAL CABLES AND PROCESSES FOR MAKING AND USING SAME | SCHLUMBERGER TECHNOLOGY CORPORATION | 2018-12-06 | — | — | US | disclosed |
| US-10000450-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2018-06-19 | — | — | US | disclosed |
| US-10000450-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2018-06-19 | — | — | US | disclosed |
| US-4725616-A | ANTIARTHRITIC AGENTS | PFIZER INC. (US) | 1988-02-16 | — | — | US | disclosed |
| EP-0208510-A2 | 1-Substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents | PFIZER INC. (US) | 1987-01-14 | — | — | EP | disclosed |
| US-4567264-A | ADRENERGIC BLOCKING AGENTS | SYNTEX (U.S.A.) INC. (US) | 1986-01-28 | — | — | US | disclosed |
| US-4558129-A | Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade | SYNTEX (U.S.A.) INC. (US) | 1985-12-10 | — | — | US | disclosed |
| US-4499100-A | CARDIOUVASCULAR DISORDERS | SYNTEX (U.S.A.) INC. (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0119428-A2 | Biscarboxamides for treating diseases, and process for their preparation | BAYER AG (DE) | 1984-09-26 | — | — | EP | disclosed |
| US-4239688-A | Herbicidal N-(haloacetyl)-N-(N'-methylenepyrrolidonyl-2-mercaptoalkylanilines | GAF CORPORATION (US) | 1980-12-16 | — | — | US | disclosed |
| US-4216152-A | Process for making N-(N'-methylenepyrrolidonyl)-2-substituted anilines | GAF CORPORATION (US) | 1980-08-05 | — | — | US | disclosed |
| US-4203901-A | Process for making N-(N'-methylenepyrrolidonyl)-2-substituted anilines | GAF CORPORATION (US) | 1980-05-20 | — | — | US | disclosed |
| US-4202821-A | N-(N'-Methylenepyrrolidonyl)-2-substituted anilines | GAF CORPORATION (US) | 1980-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000450-B2 | N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors | SLC6A2, TPH1, SLC6A3 | TLR8 4550/4885PTGS2 3295/4885MEN1 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.